ACM
ESPR icon

Altium Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Altium Capital Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-620,000
Closed -$3.86M – 95
2022
Q4 		$3.86M Sell
620,000
-39,869
-6% -$285K 1.98% 19
2022
Q3 		$4.42M Sell
659,869
-503,000
-43% -$3.45M 1.66% 15
2022
Q2 		$7.4M Sell
1,162,869
-1,333,655
-53% -$7.56M 3.13% 4
2022
Q1 		$11.6M Sell
2,496,524
-19,261
-0.8% -$82.6K 4.04% 2
2021
Q4 		$12.6M Buy
+2,515,785
New +$20.1M 3.53% 1

Other funds holding ESPR

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return